This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:


peer-reviewed publication

trusted source


Atomic picture of dengue replication could transform antiviral approaches

Atomic picture of dengue replication could transform antiviral approaches
Structures of dengue virus replication complexes, and the initiation of genome duplication (left) and during RNA elongation (right). Credit: RIKEN Center for Biosystems Dynamics Research

A detailed atomic exploration into how the dengue virus replicates its genome could catalyze the development of high-precision targeted antiviral therapeutics.

Dengue is one of the most common infections that spread from mosquitoes to people, causing fevers and aches that can sometimes lead to life-threatening complications.

Some are being developed that target different proteins involved in the replication of the dengue virus. But a better understanding of how the virus assembles and orchestrates its replication could unlock new avenues for developing more-effective alternatives.

Now, by harnessing the power of cryo-, RIKEN scientists have generated 3D images that reveal the positions of key viral proteins as they adhere to RNA molecules at various stages during the replication cycle of the mosquito-borne virus.

The structures unveiled by this cutting-edge approach help to illuminate a that has long puzzled scientists and eluded drug-discovery efforts.

"We have elucidated part of the mechanism by which the virus propagates in infected cells," says Shun-ichi Sekine of the RIKEN Center for Biosystems Dynamics Research. "These findings could lead to better for dengue virus infections."

Sekine and his team determined how two critical viral proteins—an RNA-copying enzyme called NS5 and an RNA-unwinding enzyme called NS3—interface with a small strand of RNA designed to mimic the dengue genome. The study is published in the journal Molecular Cell.

The researchers focused on two stages of viral replication: at the beginning of RNA synthesis and during RNA elongation. Their structural analyses revealed not only the intricate mechanics behind how the copies its genome, but also the molecular foundations that drive NS5's multifaceted functions during infection. A versatile protein, NS5 can suppress the antiviral capabilities of immune signaling molecules in the by binding to them.

One RNA– in particular—between NS5 and a segment of the dengue genome known as stem loop A—could prove particularly amenable to drugging with small-molecule therapeutics. The interaction, which is essential to get the replication process started, creates a physical groove termed a "thumb pocket"—exactly the type of feature that drug developers look for when designing medications.

A drug that binds at that site could dislodge NS5 and halt dengue replication in its tracks. And because this same structural element is found in the genomic RNA of related viruses, including the ones responsible for Zika infections and Japanese encephalitis, the findings could help to inspire new therapeutics for flaviviruses of all kinds.

More information: Takuo Osawa et al, Structures of dengue virus RNA replicase complexes, Molecular Cell (2023). DOI: 10.1016/j.molcel.2023.06.023

Journal information: Molecular Cell

Provided by RIKEN

Citation: Atomic picture of dengue replication could transform antiviral approaches (2023, October 31) retrieved 29 February 2024 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Broad-spectrum antiviral candidate targets dengue and SARS-CoV-2


Feedback to editors